期刊文献+

基础胰岛素联合小檗碱治疗老年2型糖尿病的临床研究 被引量:1

Basal Insulin Combined with Berberine in the Treatment of Type 2 Diabetes Mellitus in Older Patients
下载PDF
导出
摘要 目的探究在老年2型糖尿病的治疗中由预混胰岛素转换为基础胰岛素联合小檗碱治疗的临床疗效及其对餐后2 h血糖(2hPG)、糖化血红蛋白(HbA1c)、空腹血糖(FBG)指标的影响.方法选取2015年6月~2017年5月使用预混胰岛素治疗效果不理想的老年2型糖尿病患者80例,转为基础胰岛素和小檗碱联合治疗的方法,进行为期24周的治疗,仔细观察并记录患者治疗方法转换前后的2hPG、HbA1c、FBG、体质指数(BMI)、腰臀比(WHR)、空腹及餐后2hC肽水平、5点血糖水平等变化情况.结果转换治疗后的2hPG、HbA1c和FBG水平均比转换前降低,其达标率较之前显著提高(P<0.05);HbA1c>7%组与HbA1c≤6.5%组相比,其HbA1c、餐后2hC肽和HbA1c降幅的差异显著(P<0.05);HbA1c>7%水平下的三餐后血糖水平较HbA1c≤6.5%水平下的血糖水平要高(P<0.05).结论在老年2型糖尿病的治疗中由预混胰岛素转换为基础胰岛素联合小檗碱治疗具有较好的临床疗效,能够提高治疗后的血糖达标率,有效改善患者症状,提高患者的治疗满意程度,能够使患者获得更高的生活质量,无明显的不良反应,可以在临床上进行广泛的推广和应用. Objective To explore the effects of basic insulin combined with berberine on type 2 diabetes mellitus and 2-hour postprandial blood glucose(2hPG),glycosylated hemoglobin(HbA1c)and fasting blood glucose(FBG)in older patients.Methods 80 older type 2 diabetes patients with unsatisfactory therapeutic effect of premixed insulin were enrolled from June 2015 to May 2017.The premixed insulin was replaced with basal insulin plus berberine for 24 weeks in patients.The levels of 2hPG,HbA1c,FBG,body mass index(BMI),waist to hip ratio(WHR),fasting and postprandial 2hC-peptide levels,blood glucose levels at 5 time points were documented.Results The levels of 2hPG,HbA1c and FBG were lower and the control rates increased significantly when treated with basal insulin plus berberine than those when treated with premixed insulin(P<0.05).There were sig-nificant differences in the levels of HbA1c,postprandial 2hC-peptide and the decrease of HbA1c between the patients with HbA1c>7% and the patients with HbA1c≤6.5%(P<0.05).The postprandial blood glucose levels in patients with HbA1c>7% were higher than those in patients with HbA1c≤6.5%(P<0.05).Conclusion Basal insulin combined with berberine exhibits good therapeutic effect in older type 2 diabetic patients with unsatisfactory therapeutic effect of premixed insulin.
作者 张寿莉 都渝 Zhang Shouli;Du Yu(Department of Coronary Heart Disease,Qinghai Cardiovascular and Cerebrovascular Disease Hospital,Xining 810000,China)
出处 《国际老年医学杂志》 2019年第6期352-354,364,共4页 International Journal of Geriatrics
关键词 2 型糖尿病 预混胰岛素 基础胰岛素 小檗碱 临床疗效 Type 2 diabetes mellitus Premixed insulin Basal insulin Berberine Clinical efficacy
  • 相关文献

参考文献8

二级参考文献85

  • 1郭瑞金,薛元明,施珏,蔡玮.人胰岛素类似物(Insulin Aspart)持续皮下注射治疗2型糖尿病[J].中华内分泌代谢杂志,2005,21(3):278-279. 被引量:24
  • 2张丽,侯庆宁,谢晓敏.双时相门冬胰岛素与预混人胰岛素治疗2型糖尿病的疗效对比[J].宁夏医学杂志,2006,28(12):928-929. 被引量:6
  • 3卜石,郭晓蕙,杨文英,卢桂芝,杨兆军,任婷婷,高妍.预混胰岛素转为基础胰岛素联合口服降糖药治疗方案的2型糖尿病患者的临床特征分析[J].中华医学杂志,2007,87(44):3115-3118. 被引量:51
  • 4Yang WY,Lu JM,Weng JP,et al.Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362(12):1090-1091.
  • 5Standl E,Janka HU.High serum insulin conceratrations in relation toother cardiovascular risk factors in macrovasculag disease of type 2 diabetes[J].Horm M etab Res,1985,15(Suppl):46-51.
  • 6Martin DB.Atherogenicity of insulin[J].Diabetes Res Clin Pratt,1988,4(Suppl):58,61.
  • 7Feldman JM,Lebovitz HE.Appraisal of the extrapancreatic actions of sulfonylurcas[J].Arch Intem M ed,1969,123:314-322.
  • 8Muller G,Satoh Y,Geisen K.Extrapancrcatic effects of sulphonylureas a comparison betw een glimepiride and conventional sulphonylureas[J].Diabetes Res Clin Pract,1995,28(Suppl):S115-S137.
  • 9Johnson JL,Wolf SL,Kabadi UM.Efficacy of insulin and sulfonylurea combination therapy in type 2 diabetes:A meta-analysis of the randomized placebo-controlled trims[J].Arch Intern M ed,1996,156:259-264.
  • 10Strowig SM,Pe-santa ML,Raskin P,et al.Comparison of insulin monotherapy and combination therapy w ith insulin and mefformin or insulin and troglimzone in type 2 diabetes[J].Diabetes Care,2002,25:2133-2140.

共引文献137

同被引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部